Journal profile · Medicine-Oncology
Iranian Journal of Blood and Cancer
ISSN 2008-4595 · eISSN 2008-4609 · Iranian Pediatric Hematology and Oncology Society · Iran, Islamic Republic of
Iranian Journal of Blood and Cancer: fully open access; APC about USD 300; review about 8 weeks (community reports); 10 articles in 2025; indexed in Scopus.
Scope
Aims, scope and focus
Iranian Journal of Blood and Cancer is published by Iranian Pediatric Hematology and Oncology Society. By OpenAlex counts of its recent articles, its largest topics are Hemoglobinopathies and Related Disorders, Platelet Disorders and Treatments and Acute Lymphoblastic Leukemia research, together about 27.4% of its articles. Its main subfields are Hematology. (generated from OpenAlex topic counts and CAS ranking data)
Research area (LetPub): Medicine-Oncology
Editorial board by country: none in mainland China; most named Iran 19, United States 6, Italy 6, Japan 2, Switzerland 2 (42 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Hemoglobinopathies and Related DisordersMedicine11.5%
- Platelet Disorders and TreatmentsMedicine8.2%
- Acute Lymphoblastic Leukemia researchMedicine7.7%
- Acute Myeloid Leukemia ResearchMedicine6.9%
- Blood groups and transfusionMedicine6.1%
- Blood transfusion and managementMedicine5.8%
- Iron Metabolism and DisordersMedicine5.6%
- Hemophilia Treatment and ResearchMedicine5.6%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Not covered
Not covered by this edition.
CAS Xinrui Journal Ranking (March 2026)Not covered
Not covered by this edition.
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
CiteScore quartiles (Scopus, June 2026 release)
| Subject | Quartile | Rank | Percentile |
|---|---|---|---|
| Hematology | Q3 | 107/151 | — |
| Oncology | Q3 | 310/428 | — |
Scopus ranks journals by CiteScore within each subject: the 75th percentile and above is Q1, then a quartile every 25 points. A different system from the CAS zones.LetPub
Database indexing
ScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- CiteScore 2026-06
- 1.5LetPub ·
- SJR 2026-06
- 0.32LetPub ·
- SNIP 2026-06
- 0.3LetPub ·
- h-index
- 12OpenAlex ·
- i10-index
- 17OpenAlex ·
- 2-year mean citedness
- 3.03OpenAlex ·
- Share of gold OA articles
- 0%LetPub ·
Articles by year OpenAlex count · 401 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 0 | 0 | 35 |
| 2025 | 10 | 10 | 141 |
| 2024 | 30 | 30 | 116 |
| 2023 | 34 | 34 | 69 |
| 2022 | 35 | 35 | 64 |
| 2021 | 13 | 13 | 74 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
- Average review time (community reports)
- about 8 weeksLetPub ·
- Submission to publication (journal-reported)
- about 8 weeksDOAJ ·
- Peer review
- Double anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | IRR 80,000,000 / USD 300 | Yes | CC BY-NC |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- Publisher
- Iranian Pediatric Hematology and Oncology Society
- Country or region
- Iran, Islamic Republic of
- Language
- English
- ISSN
- 2008-4595
- Electronic ISSN
- 2008-4609
- Official links
- Journal homepage ↗LetPub
- Author guidelines ↗DOAJ
- Aims & Scope ↗DOAJ
- Special issues ↗Publisher website
- APC information ↗DOAJ
- Fee waivers ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗DOAJ
- Editorial board ↗DOAJ
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about Iranian Journal of Blood and Cancer
How long does peer review take at Iranian Journal of Blood and Cancer?
Authors report an average review time of about 8 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Where are the editorial board members of Iranian Journal of Blood and Cancer based?
Of the 42 board members whose country the journal's board page names, none are in mainland China; the countries named most often are Iran (19), United States (6) and Italy (6). Counted from the institutions listed on the board page; for reference only.
Which databases index Iranian Journal of Blood and Cancer?
According to LetPub and DOAJ records, Iranian Journal of Blood and Cancer is indexed in Scopus and DOAJ.
Is Iranian Journal of Blood and Cancer open access, and what is the APC?
Iranian Journal of Blood and Cancer is a fully open-access journal. APC about USD 300.
Sources and updates
The facts on this page come from LetPub, DOAJ, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .